Letters
Prostate cancer screening
Underscreened and undertreated
BMJ 2011; 342 doi: https://doi.org/10.1136/bmj.d3708 (Published 14 June 2011) Cite this as: BMJ 2011;342:d3708
- Jesse N Aronowitz, physician1
- 1University of Massachusetts Medical School, Worcester, MA 01605-2397, USA
- aronowij{at}ummhc.org
Three points question Sandblom and colleagues’ conclusion that screening for prostate cancer conferred no significant survival benefit.1
(1) A quarter of the men randomised to the screening cohort did not attend. Two thirds of …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.